Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
WGS
WGS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
WGS News
GeneDx CEO Katherine Stueland Named to TIME100 Health List 2026
4d ago
Newsfilter
Global Payments Inc (GPN) Options Trading Volume Hits 1.6 Million Shares
Jan 20 2026
NASDAQ.COM
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
Jan 19 2026
seekingalpha
GeneDx Holdings Corp (WGS) Options Volume Hits 4,198 Contracts, 109.9% of Average
Jan 12 2026
NASDAQ.COM
GeneDx Reports $427M Revenue for 2025, 41% YoY Growth
Jan 12 2026
seekingalpha
GeneDx Partners with Komodo Health to Build Comprehensive Rare Disease Dataset
Jan 08 2026
Businesswire
GeneDx Appoints Linda Genen as Chief Medical Officer to Enhance Clinical Strategy
Jan 06 2026
NASDAQ.COM
Generac Holdings Sees 7,075 Options Contracts Traded, 67.8% of Average Daily Volume
Dec 30 2025
NASDAQ.COM
Significant Options Trading on Tuesday: MSTR, WGS, ABM
Dec 16 2025
NASDAQ.COM
Eight Stock Selections to Capitalize on a Robust Sector of the Market
Dec 11 2025
MarketWatch
The Inside Scoop:
Dec 07 2025
Benzinga
GeneDx Holdings Under Investigation for Potential Shareholder Rights Breach
Nov 30 2025
PRnewswire
"Invest in GeneDx Holdings at $65 and Achieve 18.5% Returns with Options"
Nov 21 2025
NASDAQ.COM
Significant Options Trading on Tuesday: SEI, NET, WGS
Nov 18 2025
NASDAQ.COM
6 Healthcare Stocks Showing Significant Positive Momentum
Nov 18 2025
Benzinga
Canaccord Genuity Reaffirms Buy Rating on GeneDx Holdings and Increases Price Target to $160
Oct 29 2025
Benzinga
Show More News
